Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,870 | 11,951 | 13,516 | 9,485 | 0 |
| Marketable Securities | 36,509 | 38,889 | 43,437 | 1,946 | 0 |
| TOTAL | $44,446 | $51,840 | $58,117 | $11,992 | $0 |
| Non-Current Assets | |||||
| PPE Net | 134 | 154 | 111 | 109 | N/A |
| Other Non-Current Assets | 1,251 | 694 | 808 | 3,004 | 0 |
| TOTAL | $1,385 | $848 | $919 | $3,113 | $N/A |
| Total Assets | $45,831 | $52,688 | $59,036 | $15,105 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,796 | 1,600 | 1,650 | 2,212 | 0 |
| Accrued Expenses | 3,060 | 3,291 | 3,373 | 3,259 | 0 |
| TOTAL | $4,856 | $4,891 | $5,023 | $5,471 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 130,412 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $130,412 | $N/A |
| Total Liabilities | $4,856 | $4,891 | $5,023 | $135,883 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 737 | 737 | 736 | 736 | N/A |
| Common Shares | 15 | 15 | 15 | N/A | 0 |
| Retained earnings | -144,534 | -136,946 | -130,081 | -123,822 | 0 |
| Other shareholders' equity | -50 | -33 | -6 | 0 | 0 |
| TOTAL | $40,975 | $47,797 | $54,013 | $-120,778 | $0 |
| Total Liabilities And Equity | $45,831 | $52,688 | $59,036 | $15,105 | $0 |